Literature DB >> 9150350

A model system in haematology and immunology: the human monocytic cell line MONO-MAC-1.

K G Steube1, D Teepe, C Meyer, M Zaborski, H G Drexler.   

Abstract

MONO-MAC-1 is a human cell line with properties of blood monocytes, which can be used as a model system to study monocytic functions in vitro. In the present study, we prepared a karyotype of MONO-MAC-1, analysed the growth behaviour, determined the presence of differentiation-associated antigens and studied the expression and secretion of several cytokines upon stimulation with 12-O-tetradecanoyl phorbol 13-acetate (TPA) and lipopolysaccharide (LPS). The MONO-MAC-1 cells have a near diploid karyotype and contain several recurrent chromosomal rearrangements, in particular the translocation (9;11) commonly found in AML-M5. Stimulation with TPA or LPS induced changes in morphology and gene expression, especially an increase in the level of the differentiation marker CD14 and the production of monocyte-related cytokines. Both biomodulators alone were sufficient to promote TNF alpha release; however, the combination of TPA and LPS resulted in a synergistic increase of TNF alpha secretion. Northern blot analysis indicated that upregulated production of TNF alpha was due to induced synthesis of mRNA. The mRNA accumulation peaked approximately 2 h after stimulation and maximum levels of TNF alpha were found in the supernatants after 4-8 h of culture. The MONO-MAC-1 cells could not be restimulated with the same inducer to release TNF alpha when a 48 h pre-treatment was carried out with LPS or TPA. LPS induced the release of granulocyte colony-stimulating factor (G-CSF), while TPA failed to do so. Vice versa, secretion of macrophage CSF (M-CSF) could be induced by TPA, but not by LPS. However, LPS enhanced the TPA-induced M-CSF production. Similarly, incubation of MONO-MAC-1, simultaneously with TPA and LPS, led to granulocyte macrophage CSF (GM-CSF) and interleukin-1beta (IL-1beta)secretion, while both stimulators alone had almost no (TPA) or only a weak (LPS) effect on the secretion of GM-CSF and IL-1beta. Our results demonstrate that MONO-MAC-1 is a unique cell line with distinct monocytic features; certain monocytic properties can be upregulated by activation of intracellular signalling pathway(s). We suggest that, besides the LPS receptor CD14, activation of PKC participates in these process, especially in the production and secretion of cytokines by MONO-MAC-1 cells.

Entities:  

Mesh:

Year:  1997        PMID: 9150350     DOI: 10.1016/s0145-2126(96)00129-4

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

1.  Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.

Authors:  Michael J V White; David Roife; Richard H Gomer
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

2.  An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.

Authors:  Ge Jin; Hameem I Kawsar; Stanley A Hirsch; Chun Zeng; Xun Jia; Zhimin Feng; Santosh K Ghosh; Qing Yin Zheng; Aimin Zhou; Thomas M McIntyre; Aaron Weinberg
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

3.  Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations.

Authors:  Hanna S Radomska; Daniela S Bassères; Rui Zheng; Pu Zhang; Tajhal Dayaram; Yukiya Yamamoto; David W Sternberg; Nathalie Lokker; Neill A Giese; Stefan K Bohlander; Susanne Schnittger; Marie-Hélène Delmotte; Roger J Davis; Donald Small; Wolfgang Hiddemann; D Gary Gilliland; Daniel G Tenen
Journal:  J Exp Med       Date:  2006-01-30       Impact factor: 14.307

4.  XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells.

Authors:  Daniel Moreno-Martínez; Meritxell Nomdedeu; María Carmen Lara-Castillo; Amaia Etxabe; Marta Pratcorona; Niccolò Tesi; Marina Díaz-Beyá; María Rozman; Emili Montserrat; Alvaro Urbano-Ispizua; Jordi Esteve; Ruth M Risueño
Journal:  Oncotarget       Date:  2014-06-30

5.  Molecular and Cellular Impact of Inflammatory Extracellular Vesicles (EVs) Derived from M1 and M2 Macrophages on Neural Action Potentials.

Authors:  Sarah Vakili; Taha Mohseni Ahooyi; Shadan S Yarandi; Martina Donadoni; Jay Rappaport; Ilker K Sariyer
Journal:  Brain Sci       Date:  2020-07-03

6.  CCR7 Receptor Expression in Mono-MAC-1 Cells: Modulation by Liver X Receptor α Activation and Prostaglandin E 2.

Authors:  Bérengère Tanné; Stéphane Bernier; Nancy Dumais
Journal:  Int J Inflam       Date:  2015-12-06

7.  Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells.

Authors:  Josep Maria Cornet-Masana; Daniel Moreno-Martínez; María Carmen Lara-Castillo; Meritxell Nomdedeu; Amaia Etxabe; Niccolò Tesi; Marta Pratcorona; Jordi Esteve; Ruth M Risueño
Journal:  Oncotarget       Date:  2016-04-26

8.  Repositioning of bromocriptine for treatment of acute myeloid leukemia.

Authors:  María Carmen Lara-Castillo; Josep Maria Cornet-Masana; Amaia Etxabe; Antònia Banús-Mulet; Miguel Ángel Torrente; Meritxell Nomdedeu; Marina Díaz-Beyá; Jordi Esteve; Ruth M Risueño
Journal:  J Transl Med       Date:  2016-09-07       Impact factor: 5.531

9.  The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines.

Authors:  Stine Emilie Weis-Banke; Mie Linder Hübbe; Morten Orebo Holmström; Mia Aaboe Jørgensen; Simone Kloch Bendtsen; Evelina Martinenaite; Marco Carretta; Inge Marie Svane; Niels Ødum; Ayako Wakatsuki Pedersen; Özcan Met; Daniel Hargbøl Madsen; Mads Hald Andersen
Journal:  Oncoimmunology       Date:  2020-06-01       Impact factor: 8.110

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.